Evaluation of the screening questionnaire "Düsseldorfer Instrument zum Borderline-Screening" (abbr: DIBS) for the diagnosis and severity classification of a borderline personality disorder.

Evaluation of the screening questionnaire "Düsseldorfer Instrument zum Borderline-Screening" (abbr: DIBS) for the diagnosis and severity classification of a borderline personality disorder. - DIBS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024190

Enrollment

Registered

2021-02-12

Start date

2021-03-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F60.31

Interventions

Group 1: Group 1: Borderline patient group. After consenting to participate in the study and verifying the participation prerequisites the participant will first complete the new DIBS questionnaire.

Eligibility

Sex/Gender

All

Age

16 Years to 65 Years

Inclusion criteria

Inclusion criteria: - Patients with a diagnosis of borderline personality disorder according to DSM-5 as their primary diagnosis, - or patients who do not have a diagnosis of borderline personality disorder according to DSM-5, but who have Have at least one of the following DSM-5 diagnoses: bipolar disorder, schizoaffective disorder, depression, acute psychosis, schizophrenia, narcissistic personality disorder, histrionic Personality Disorder, Dependent Personality Disorder, Anxious-Avoidant Personality Disorder, obsessive-compulsive personality disorder, addiction, PTSD, autism spectrum disorder, eating disorders. - Sufficient German language skills - Age between 16-65 years - Existing ability to give consent or consent from a legal guardian for patients under the age of 18 years - Voluntary participation

Exclusion criteria

Exclusion criteria: - Age 25) or organic affective disorder.

Design outcomes

Primary

Measure	Time frame
The primary endpoints of the study are to assess the validity, reliability, and diagnostic accuracy of the initial "diagnostic portion" of the screener versus the current diagnost. gold standard, the structured clinical interview (using the Structural Clinical Interview for DSM-5 (SCID-5-PD; First et al., 2016)) and the validity, reliability, and accuracy of the severity classifier against an expert assessment of clinical severity according to the Clinical Global Impression-Severity scale (CGI-S; Guy, 1976). The CGI-S is a 7-point scale that asks clinicians to rate the severity of the patient's illness at the time of assessment relative to their previous experience with patients with the same diagnosis.	—

Measure

Time frame

The primary endpoints of the study are to assess the validity, reliability, and diagnostic accuracy of the initial "diagnostic portion" of the screener versus the current diagnost. gold standard, the structured clinical interview (using the Structural Clinical Interview for DSM-5 (SCID-5-PD; First et al., 2016)) and the validity, reliability, and accuracy of the severity classifier against an expert assessment of clinical severity according to the Clinical Global Impression-Severity scale (CGI-S; Guy, 1976). The CGI-S is a 7-point scale that asks clinicians to rate the severity of the patient's illness at the time of assessment relative to their previous experience with patients with the same diagnosis.

—

Countries

Germany

Contacts

Public ContactMilenko Kujovic

LVR Klinikum Düsseldorf

Milenko.Kujovic@lvr.de0211 922-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026